cancer test 2 breast cancer Flashcards

1
Q

risk factors for breast cancer

A

female
increased age
alcohol
personal history of breast cancer
hormonal factors
nulliparity or late age of 1st pregnancy
not breastfeeding for up to a year
hormonal replacement therapy
dense breast tissue
late menopause
family history of breast cancer
BRCA 1 and BRCA 2 mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

modifiable risk factors for breast cancer

A

-obesity and weight gain after menopause
-high-fat diet
-sedentary lifestyle
-alcohol
-smoking
-night shift

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

malignant signs for breast cancer

A

nontender, poorly defined hard lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

advanced signs of malignant breast cancer

A

skin dimpling, nipple retraction, skin ulceration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

to detect any malignancies that r in the ducts if they have abnormal discharge from the nipple

A

galactography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

gold standard for women with average risk of breast cancer. usually done every year

A

mammography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

gold standard surgical biopsy for palpable breast tumors. aka lumpectomy

A

excisional biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what agents should be discontinued for someone getting a surgical biopsy

A

anything that can increase risk of bleeding like ASA, NSAIDS, vitamin E, ginkgo, garlic, coumadin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

some benign conditions of the breast

A

mastalgia
cysts (fibrocystic breast disease)
fibroadenomas
atypical hyperplasia
lobular carcinoma in situ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

two non cancerous breast diseases that can increase risk for cancer

A

-atypical hyperplasia
-lobular carcinoma in situ (LCIS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

proliferation of malignant cells inside milk ducts without invasion

A

ducati carcinoma in situ (DCIS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DCIS

A

-will turn invasive if not treated
-mammogram to show calcifications
-considered stage 0 breast cancer
-diagnosed with biopsy
- estrogen most common reason for this type of cancer
- breast conservation treatment (lumpectomy, wide excision, segmental mastectomy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

-caused by malignant cells that r blocking the lymph channels in the skin. sometimes mistaken as infection
-orange
-chemo, radiation, then surgery

A

peau d’orange (inflammatory)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

malignancy of mammary ducts

A

paget’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

early sign of pagets

A

nipple and areola may have redness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

late sign of pagets

A

scaling and thick, looks eroded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

stage 0 breast cancer characterization

A

in situ, early type of breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

stage 1 breast cancer characterized

A

localized tumor <1 inch in diameter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

stage 2 breast cancer characterized

A

tumor 1-2 inches in diameter, spread to axillary lymph nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

stage 3 breast cancer characterized

A

tumor 2 inches or larger, spread to other lymph nodes and tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

stage 4 breast cancer characterized

A

cancer has metastasized to other body organs

22
Q

prevention strategies in high risk patient for breast cancer

A

-combo of genetic, hormonal, environmental
-long term surveillance
-chemo prevention (tamoxifen and raloxifene)
-prophylactic mastectomy

23
Q

clinical manifestations of breast cancer

A

-upper outer quadrant
-nontender, fixed and hard with irregular borders
-no s and s other than a mammographic abnormality

24
Q

determines staging and prognosis for breast cancer

25
Q

goal of surgery for breast cancer

A

to regain control of the disease

26
Q

lumpectomy, wide excision, partial or segmental mastectomy

A

breast conservation treatment

27
Q

indications for mastectomy

A

-history of radiation to breast or chest wall
-inflammatory breast cancer
-diffuses suspicious or malignant appearing calcifications
-widespread disease
-positive margins after repeat re-excision
-tumors greater than 5cm in diameter
-focally positive margins
-<35 yr olds, BRCA1 or 2 mutations

28
Q

treats invasive breast cancer
-removal of breast, nipple, areola, and a portion of axillary lymph node

A

modified radical mastectomy

29
Q

removes breast, nipple, and areola but not the axillary lymph nodes
-usually for non invasive breast cancers like DCIS

A

total/ simple mastectomy

30
Q

most important prognostic factor in breast cancer

A

status of lymph nodes

31
Q

shorter operating room time

32
Q

longer operating room time

33
Q

no surgical drain

34
Q

has surgical drain

35
Q

lymphedema risk minimal

36
Q

lymphedema risk higher

37
Q

presence of neuropathic sensations postoperatively

38
Q

decreased rom post op

39
Q

seroma may occur post op

40
Q

who’s not a good candidate for tissue expander

A

woman who’s had radiation or connective tissue disease

41
Q

what can’t someone get done with a tissue expander in

42
Q

who’s not a good candidate for TRAM flap

A

diabetes or other comorbidities

43
Q

complications of TRAM flap

A

-breathing because they don’t take deep breaths due to abdomen surgery
at risk for DVTs and atelectasis

44
Q

post op education for breast surgery

A

-tenderness, soreness, tingling will go away
-can have neuropathic pain after chronically

45
Q

doxorubicin, cyclophosphamide, paclitaxel (chemo) can cause what SE

A

cardiac toxicity and bone marrow suppression, n/v, alopecia, mucositis, anaphylactic, weight gain, taste changes, skin changes, fatigue, neuropathy, amenorrhea

46
Q

management of bone marrow suppression

A

neupogen, neulasta
erythropoietin

47
Q

premenopausal tend to be

A

estrogen receptors negative

48
Q

post menopausal women tend to be

A

estrogen receptors positive

49
Q

treats hormone receptor plus breast cancer

50
Q

treats osteoporosis in post menopausal women

A

raloxifene

51
Q

anastrozole
exemestane

A

aromatose inhibitors (lower estrogen levels)

52
Q

SE of hormonal therapy for breast cancer

A

hot flashes, night sweats, vaginal dryness, discharge, bleeding, mood disturbances, DVTs or PEs, bone thinning, osteoporosis